In true fashion, Optimus Transformative Medicine continues to be a leader in aesthetics as they introduce VIRTUE RF, the next generation in RF microneedling and the first, ever, Microneedling Platform!
Yes, it’s true your RF Microneedling skin renewal system has arrived, in a single platform! With the ability to target unwanted scars and wrinkles, it simultaneously tightens the skin.
In response to highly sought after, minimally invasive treatments, VIRTUERF allows patients to combat the fine lines and wrinkles that have set in, in addition to unwanted scars, including acne. With virtually zero down time, our team of aesthetic experts, coupled with the most advanced RF Microneedling platform available, you’ll enjoy ‘filter free’ and ‘make-up’ free photos in short order.
VIRTUERF is the newest generation of radio frequency microneedling, with FDA-clearance for your safety. Optimus Transformative Medicine is the first to offer this minimally-invasive treatment that helps stimulate natural production of collagen in the [geographic market]. The VIRTUERF also treats unwanted wrinkles, fine lines, while tightening and toning the face, neck, hands, and body.
Offering a truly comfortable patient experience via VIRTUERF’s precise robotic motor the treatment is unmatched to comparative devices you’ll find in the market. The VIRTUERF experience includes the use of a compounded numbing cream and a tandem first in market electro current post treatment mask to ensure an unprecedented recovery and absence of visible evidence that you had a treatment today. Results are immediate and improve as time passes, providing the best of both worlds.
If you are seeking optimal results, The VIRTUERF Experience delivers.
IS VIRTUERF FOR ME?
- Alleviate Wrinkles & Fine Lines
- Tighten Skin
- Minimize Pore Size
- Improve Skin Tone & Texture
- Immediate Results
- No Downtime
- Virtually Pain-Free
Contact Optimus Transformative Medicine today, to schedule your next generation, VIRTUERF Microneedling treatment and discover renewed skin CLICK HERE.